Skip to content

A randomized clinical study to evaluate Ayurvedic nasal oil administration in Bell s palsy

A Randomized Controlled Clinical Trial Assessing the Efficacy of Vatanashaka Gana Taila Nasya Karma in Patients with Ardita (Bell s Palsy). - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102700
Enrollment
40
Registered
2026-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system Health Condition 2: G998- Other specified disorders of nervous system in diseases classified elsewhere Health Condition 3: R298- Other symptoms and signs involvingthe nervous and musculoskeletal systems

Interventions

None listed

Sponsors

Dr. Kavya Nandi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient presenting with classical signs and symptoms of Ardita with in 1 year. 2. Patients from either gender were selected in the age group of 16-60 years. 3. Patients fit for Nasya Karma.

Exclusion criteria

Exclusion criteria: 1. Ardita associated with Pakshagata, Bilateral facial nerve paralysis, intracranial hemorrhage, neoplasm, Multiple sclerosis, Myasthenia gravis. 2. Patient with other systemic disorders which interfere with course of treatment, and auto immune disorders. 3. Un-controlled diabetic mellitus 4. Pregnant women.

Design outcomes

Primary

MeasureTime frame
There is significant effect of vata nashaka gana taila nasya karma over Karpasathyadi tila nasya karma in Ardita.Timepoint: 28days

Secondary

MeasureTime frame
Improvements in signs and symptoms of Ardita.Timepoint: 28days

Countries

India

Contacts

Public ContactDrLatha L U

Shree Jagadguru Gavisiddheshwara Ayurvedic Medical College and Hospital

gurumahantesh@gmail.com9964061939

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026